Geneoscopy

Origin: MO | Grant Awarded: 2016 | Status: Active

Visit Website →

What is Geneoscopy?

Geneoscopy is the developer of next-generation diagnostics designed to treat digestive diseases and offer cancer screening. The company’s diagnostics help in consistently extracting stool-derived eukaryotic RNA (seRNA) transcripts and detecting changes in gene expression, enabling doctors to better prevent, detect, and guide treatment for gastrointestinal disease.

Company Leadership

Erica Barnell

Chief Executive Officer

Erica has both a B.S. in Biological Sciences and in Applied Economics and Management from Cornell University. Erica previously worked for six years as a Research Technician at Washington University School of Medicine to evaluate the malnutrition of children in Africa. Erica won first place in the 2013 Big Idea Competition at Cornell.

Connect on LinkedIn →

Andrew Barnell

Chief Finance Officer

Andrew received a B.S. in Applied Economics and Management from Cornell and is completing an MBA in Healthcare Management & Entrepreneurial Management from the Wharton School. Andrew spent two years in J.P. Morgan’s healthcare investment banking group in New York working on a variety of transactions primarily in the biotech, medical devices, and life science tools sectors, as well as two years working at Lindsay Goldberg, a middle-market private equity firm focused on providing long-term growth capital for family owned businesses.

Connect on LinkedIn →

Yiming Kang

Chief Technology Officer

Yiming has a B.S. in Biomedical Engineering from the University of Utah and an M.Eng in Biomedical Engineering from Cornell University. Yiming is also pursuing a Ph.D. in Computer Science at Washington University in St. Louis.

Connect on LinkedIn →

Involved Industries

Be a Part of the Movement

We champion extraordinary entrepreneurs to create positive change – for St. Louis and for the world. Join us by applying to our Global Startup Competition, becoming a financial supporter, volunteering your time or amplifying our message.